Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2010
05/06/2010US20100115659 Differential expression of subgenome specific alleles in cotton and uses thereof
05/06/2010US20100115658 Disease Resistant Plants
05/06/2010US20100115657 Sweet pepper hybrid 9941819
05/06/2010US20100115656 Sweet pepper hybrid 9927864
05/06/2010US20100115655 Sweet pepper hybrid 9930417
05/06/2010US20100115653 Cotton variety 07w902df
05/06/2010US20100115652 Cotton variety 07w903df
05/06/2010US20100115651 Mutant Allele of Watercress
05/06/2010US20100115650 Herbicide-Resistant Brassica Plants and Methods of Use
05/06/2010US20100115642 Xenogenic immune system in a non-human mammal
05/06/2010US20100115641 Gfp-transfected clon pig, gt knock-out clon pig and methods for productions thereof
05/06/2010US20100115640 Methods for Conditional and Inducible Transgene Espression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells
05/06/2010US20100115639 Antibodies inhibiting c-met dimerization and uses thereof
05/06/2010US20100115636 Pig model for breast cancer, mitochondria related protein folding disorders and/or epidermolysis bullosa simplex
05/06/2010US20100113840 Plants with altered carbon allocation
05/06/2010US20100113811 Delta-15 desaturases genes suitable for increasing levels of omega-3 fatty acids
05/06/2010US20100113761 siRNA targeting beta secretase (BACE)
05/06/2010US20100113760 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing
05/06/2010US20100113755 Isolated modified human chorionic gonadotropin proteins
05/06/2010US20100113750 Novel scavenger receptor
05/06/2010US20100113749 Novel scavenger receptor
05/06/2010US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same
05/06/2010US20100113695 High capacity non-viral vectors
05/06/2010US20100113582 Methods and compositions for treating hiv infections
05/06/2010US20100113574 Polynucleotides for enhancing expression of a polynucleotide of interest
05/06/2010US20100113569 Isolated dna fragment of the human a33 promoter and its use to control the expression of a heterologous gene in tumor cells
05/06/2010US20100113567 Recombinant VSV For The Treatment of Tumor Cells
05/06/2010US20100113566 Nucleic acid for treatment or prevention of immunodeficiency virus infection
05/06/2010US20100113565 Immunostimulatory combinations and methods
05/06/2010US20100113562 Therapeutic targets and molecules
05/06/2010US20100113561 Microrna molecules
05/06/2010US20100113558 Compounds and methods
05/06/2010US20100113470 Bcr-abl variants
05/06/2010US20100113383 Bifidobacterial gene sequences and their use
05/06/2010US20100113369 Means for preventing and treating cellular death and their biological applications
05/06/2010US20100113361 Anti-ige vaccines
05/06/2010US20100113355 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
05/06/2010US20100113354 Therapeutic agent comprising vasohibin
05/06/2010US20100113340 Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof
05/06/2010US20100113335 Compositions and methods for treatement of cancer
05/06/2010US20100113332 Method of treating an inflammatory disease by double stranded ribonucleic acid
05/06/2010US20100113306 siRNA Targeting connective tissue growth factor (CTGF)
05/06/2010US20100113304 Compatible display vector systems
05/06/2010US20100113303 Polypeptide Display Libraries and Methods of Making and Using Thereof
05/06/2010US20100113300 T cell receptor display
05/06/2010US20100113292 Methods of obtaining active antisense compounds
05/06/2010US20100113273 Antidesiccant
05/06/2010US20100112702 Method designed to divert glucose away from the glycolytic pathway
05/06/2010US20100112701 Reductase, gene thereof and method of using the same
05/06/2010US20100112688 Screening Methods for Compounds that Modulate the Activity of G-Protein Coupled Receptors
05/06/2010US20100112687 Nucleic acid compounds for inhibiting erbb family gene expression and uses thereof
05/06/2010US20100112686 Short hairpin rnas for inhibition of gene expression
05/06/2010US20100112685 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities
05/06/2010US20100112674 Microcin h47 plasmid selection system
05/06/2010US20100112673 Dna sequence encoding penicillin acylase, novel recombinant dna constructs and recombinant microorganisms carrying this sequence
05/06/2010US20100112671 Host Cells for Production of Isoprenoid Compounds
05/06/2010US20100112666 Dehalogenases, Nucleic Acids Encoding Them and Methods for Making and Using Them
05/06/2010US20100112657 Nucleic acids and constructs for increasing galactose catabolism and methods therefor
05/06/2010US20100112651 Nucleotide sequences that encode enzymes that change carbon flux through metabolic pathways that lead to lactic acid or fumarate production in a host cell, such as a R. oryzae cell
05/06/2010US20100112648 (r)-hydroxynitrile lyase from brassicaceae
05/06/2010US20100112640 Polynucleotide
05/06/2010US20100112639 Enhanced production and purification of a natural high intensity sweetener
05/06/2010US20100112637 Polypeptides Having Alpha-Amylase Activity and Polynucleotides Encoding Same
05/06/2010US20100112636 Inducible/regulated gene expression system in e coli
05/06/2010US20100112635 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
05/06/2010US20100112634 Yeast strains autonomously producing steroids
05/06/2010US20100112616 NOVEL BETA-GALACTOSIDE-a2,6-SIALYLTRANSFERASE, A GENE ENCODING THEREOF, AND A METHOD FOR ENHANCING ENZYME ACTIVITY
05/06/2010US20100112602 Protein-Protein Interaction Biosensors and Methods of Use Thereof
05/06/2010US20100112593 Method of Predicting the Clinical Response to Chemotherapeutic Treatment with Alkylating Agents
05/06/2010US20100112591 Tumor Suppressor Gene
05/06/2010US20100112587 Transcriptomic biomarkers for individual risk assessment in new onset heart failure
05/06/2010US20100112582 Gene encoding labyrinthin, a marker for cancer
05/06/2010US20100112577 Apparatus and methods for efficient processing of biological samples on slides
05/06/2010US20100112548 Kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus
05/06/2010US20100112182 Cotton variety 06t201f
05/06/2010US20100112080 MULTIMERIC Fc RECEPTOR POLYPEPTIDES INCLUDING A MODIFIED Fc DOMAIN
05/06/2010US20100112071 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
05/06/2010US20100112042 Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
05/06/2010US20100111992 Cytomegalovirus peptides and methods of use thereof
05/06/2010US20100111991 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
05/06/2010US20100111990 Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected Women
05/06/2010US20100111989 Rsv f-protein and its use
05/06/2010US20100111988 Small peptide for anti-angiogenesis and use thereof
05/06/2010US20100111978 Conjugates between a variant staphylococcal enterotoxin e superantigen and a targeting antibody that binds to a cancer-associated cell surface structure
05/06/2010US20100111977 Methods and compositions for treatment of myotonic dystrophy
05/06/2010US20100111974 Treatment of Cachexia
05/06/2010US20100111971 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
05/06/2010US20100111965 Combination therapy
05/06/2010US20100111961 Compositions and methods for diagnosing or treating psoriasis
05/06/2010US20100111959 Engineered anti-il-13 antibodies, compositions, methods and uses
05/06/2010US20100111956 antigen polypeptide for the diagnosis and/or treatment of ovarian cancer
05/06/2010US20100111952 Treatment of autoimmune disorders
05/06/2010US20100111942 Combination therapy for the treatment of ocular neovascular disorders
05/06/2010US20100111939 Monoclonal antibody and use thereof
05/06/2010US20100111925 Compositions of Engineered Human Arginases and Methods for Treating Cancer
05/06/2010US20100111924 Chromosomal Modification Involving the Induction of Double-Stranded DNA Cleavage and Homologous Recombination at the Cleavage Site
05/06/2010US20100111911 Mitochondrial nucleic acid delivery systems
05/06/2010US20100111907 Methods and compositions for gene inactivation
05/06/2010US20100111903 Compositions produced using enteric pathogens and methods of use
05/06/2010US20100111869 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
1 ... 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 ... 4023